$0.00
(0.00%
) Quote detailsUSD
$0.00
(0.00%
)At Close (As of Dec 3, 2025)
$4.77M
Market Cap
-
P/E Ratio
-0.75
EPS
$2.18
52 Week High
$0.12
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Clearmind Medicine Inc. (CMND) is a Vancouver-based preclinical pharmaceutical innovator dedicated to developing advanced psychedelic therapies aimed at addressing critical unmet needs in mental health care. With a robust pipeline and a focus on the exploration of psychedelic compounds, the company seeks to revolutionize treatment methodologies for neglected mental health challenges. By combining rigorous scientific research with a commitment to regulatory compliance, Clearmind is strategically poised to lead in the emerging psychedelic therapeutics sector, driving significant advancements in mental health solutions.
LPTX
VRAX
VHAI
IPG
ASST
ADAP
PFE
NIO
NVDA
ITUB
PLTD
MTSR
PCG
BA
IREN
VALE
LUMN
AMCR
PMAX
MRVL
HTOO
RR
AKTX
BITF
PLUG
KDLY
SAND
BMY
INTC
CDE
AUR
SHOT
ZAPP
CAPR
ARTL
ASBP
NFLX
HIMS
ALIT
CPNG
AEO
SCHW
CAG
TXN
AMAT
GOOGL
TEVA
APH
MDLZ
CLSK
AAL
GTLB
BSX
QBTS
VGFC
CVS
NEHC
CRM
AMD
IVVD
MSFT
SYM
LPTX
VRAX
VHAI
IPG
ASST
ADAP
PFE
NIO
NVDA
ITUB
PLTD
MTSR
PCG
BA
IREN
VALE
LUMN
AMCR
PMAX
MRVL
HTOO
RR
AKTX
BITF
PLUG
KDLY
SAND
BMY
INTC
CDE
AUR
SHOT
ZAPP
CAPR
ARTL
ASBP
NFLX
HIMS
ALIT
CPNG
AEO
SCHW
CAG
TXN
AMAT
GOOGL
TEVA
APH
MDLZ
CLSK
AAL
GTLB
BSX
QBTS
VGFC
CVS
NEHC
CRM
AMD
IVVD
MSFT
SYM